Ausnutria Dairy Corporation Ltd — Cyborg Score 5/10

Strategic Profile

In 2024, Ausnutria achieved operating revenue of approximately RMB7.402 billion with profit attributable to equity holders of approximately RMB236 million, realizing dual growth in revenue and profit. The company's international business has become a significant growth driver with 68.2% year-on-year growth in 2024.

Cyborg Score Rationale

Revenue growth remains modest at 0.3% year-on-year in 2024, though profit grew 35.3%. Stock performance has declined 11.01% over the past year. Strong international expansion offers upside potential but operational momentum appears constrained.

Top Insights

• International business emerged as a significant growth driver with 68.2% year-on-year growth in 2024
• Profit grew 35.3% year-on-year in 2024, significantly outpacing modest 0.3% revenue growth, indicating improved operational efficiency
• As of mid-June 2026, stock price stood at 1.94 HKD with recent volatility
• Ausnutria is a subsidiary of HongKong Jingang Trade Holding Company Limited

Named Competitors

• Infant Formula — Global infant nutrition leader
• Dairy Products — Leading Chinese dairy manufacturer
• Nutrition Products — Major Chinese dairy and nutrition producer

Recent Developments

• (April 2025) Released 2024 full-year results showing RMB7.402 billion revenue and 35.3% profit growth
• (April 2025) Disclosed international business achieved 68.2% year-on-year growth in 2024
• (June 2026) Stock trading at 1.94 HKD on HKEX with mixed technical signals

Open the full interactive Ausnutria Dairy Corporation Ltd report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.